P1142: Antibiotic use in the twelve months prior to ileal pouch-anal anastomosis increases the risk for pouchitis: A population-based Danish cohort studyECCO'24Year: 2024
Authors: Barnes, E.(1)*;Karachalia Sandri, A.(2);Herfarth, H.(1);Jess, T.(3);
(1)University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill, United States;(2)Aalborg University, Center for Molecular Prediction of Inflammatory Bowel Disease, Copenhagen, Denmark;(3)Aalborg University, Center for Prediction of Inflammatory Bowel Disease, Copenhagen, Denmark;
P1143: Per- and poly-fluoroalkyl substances (PFAS) exposure is associated with later occurrence of inflammatory bowel diseaseECCO'24Year: 2024
Authors: Agrawal, M.(1)*;Midya, V.(2);Maroli, A.(3);Valvi, D.(2);Magee, J.(4);Ungaro, R.(1);Porter, C.(5);Petrick, L.(2,6);Colombel, J.F.(1);
(1)Icahn School of Medicine at Mount Sinai, The Dr. Henry D. Janowitz Division of Gastroenterology, New York, United States;(2)Icahn School of Medicine at Mount Sinai, Department of Environmental Medicine and Public Health, New York, United States;(3)Icahn School of Medicine at Mount Sinai, Department of Environmental Medicine and Public Health- Icahn School of Medicine at Mount Sinai, New York, United States;(4)Walter Reed National Military Medical Center- Bethesda, Gastroenterology, Bethesda, United States;(5)Naval Medical Research Command, Translational and Clinical Research Department, Silver Spring, United States;(6)Sheba Medical Center, The Bert Strassburger Metabolic Center, Tel-Hashomer, Israel;PREDICTS study group
P1145: Assessing disease control in inflammatory bowel disease (IBD) – a real world cross-sectional study in the UK.ECCO'24Year: 2024
Authors: de Silva, S.(1)*;Steed, H.(2);Allen, P.B.(3);Vegad, C.(4);Crooks, J.(5);Jaulim, A.(4);Hart, A.(6);
(1)Russells Hall Hospital- Dudley Group NHS Foundation Trust, Gastroenterology, Dudley, United Kingdom;(2)The Royal Wolverhampton NHS Trust, Gastroenterology, Wolverhampton, United Kingdom;(3)The Ulster Hospital, Gastroenterology, Belfast, United Kingdom;(4)AbbVie Ltd, Gastroenterology, Maidenhead, United Kingdom;(5)Abbvie Ltd, Gastroenterology- Global Medical Affairs GMA, Maidenhead, United Kingdom;(6)St Mark@E@s Hospital- The National Bowel Hospital, Department of Inflammatory Bowel Disease, London, United Kingdom;
P1147: Symptoms of irritable bowel syndrome are common in patients in remission from Inflammatory Bowel Disease: Results from an observational population-based cohort study in NorwayECCO'24Year: 2024
Authors: Olsen, B.(1,2)*;Opheim, R.(3,4);Kristensen, V.A.(3);Høivik, M.L.(2,3);Lund, C.(2,3);Aabrekk, T.B.(2,5);Johansen, I.(4,6);Aass Holten, K.I.(2,7);Strande, V.(2,8,9);Frivold Glad, I.(2,8,9);Bengtson, M.B.(5);Ricanek, P.(8);Detlie, T.E.(2,10);Medhus, A.W.(2,3);Boyar Cetinkaya, R.(11);Torp, R.(12);Vatn, S.(2,10,13);Frigstad, S.O.(14);Bernklev, T.(2,15);Jelsness-Jørgensen, L.P.(6,7);Huppertz-Hauss, G.(1,2);
(1)Telemark Hospital Trust, Dept. of Gastroenterology, Skien, Norway;(2)University of Oslo, Institute of Clinical Medicine, Oslo, Norway;(3)Oslo University Hospital, Dept. of Gastroenterology, Oslo, Norway;(4)University of Oslo, Inst. of Health and Soc.- Dept. of Public Health, Oslo, Norway;(5)Vestfold Hospital Trust, Dept. of Gastroenterology, Tønsberg, Norway;(6)Østfold University College, Faculty of Health- Welfare and Org., Fredrikstad, Norway;(7)Østfold Hospital Trust, Dept. of Gastroenterology, Sarpsborg, Norway;(8)Lovisenberg Diaconal Hospital, Dept. of Gastroenterology, Oslo, Norway;(9)Unger-Vetlesen Inst., Lovisenberg Diaconal Hospital, Oslo, Norway;(10)Akershus University Hospital, Dept. of Gastroenterology, Lørenskog, Norway;(11)Diakonhjemmet Hospital, Dept. of Medicine, Oslo, Norway;(12)Hamar Hospital, Dept. of Medicine- Innlandet Hospital Trust, Hamar, Norway;(13)Innlandet Hospital Trust, Dept. of Medicine, Gjøvik, Norway;(14)Baerum Hospital, Dept. of Medicine- Vestre Viken Hospital Trust, Gjettum, Norway;(15)Vestfold Hospital Trust, Research and Development, Tønsberg, Norway;IBSEN III
P1149: Risk of Clostridioides difficile infection in patients with inflammatory bowel diseaseECCO'24Year: 2024
Authors: Martinez Lozano, H.(1)*;Saralegui Gonzalez, P.(1);Fueyo Peláez, P.R.(1);García García, A.(1);Miranda-Bautista, J.(1);Reigadas Ramírez, E.(2);Alcalá Hernández, L.(2);Muñoz García, P.(2);Marín-Jiménez, I.(1);Menchén, L.(1);
(1)Gregorio Marañón General University Hospital, Gastroenterology, Madrid, Spain;(2)Gregorio Marañón General University Hospital, Microbiology, Madrid, Spain;
P114: Role of NLRX1 Agonist NX-13 in Reducing Visceral Hypersensitivity in Preclinical Gastrointestinal InflammationECCO'24Year: 2024
Authors: Verstockt, B.(1)*;Vermeire, S.(2);Peyrin-Biroulet, L.(3);Yarur, A.(4);Panaccione, R.(5);Mosig, R.(6);Cataldi, F.(7);Danese, S.(8);
(1)University Hospitals Leuven- KU Leuven-, Department of Gastroenterology and Hepatology- Department of Chronic Diseases and Metabolism, Leuven, Belgium;(2)University Hospitals Leuven- KU Leuven, Department of Gastroenterology and Hepatology- Department of Chronic Diseases and Metabolism, Leuven, Belgium;(3)Nancy University Hospital- University of Lorraine- Paris IBD center- McGill University Health Centre-, Department of Gastroenterology- INSERM- NGERE- INFINY Institute- FHU-CURE- Groupe Hospitalier privé Ambroise Paré - Hartmann-Division of Gastroenterology and Hepatology, Vandoeuvre-les-Nancy, France;(4)Cedars Sinai Medical Center, Division of Gastroenterology and Hepatology- Center for Inflammatory Bowel Diseases, Los Angeles, United States;(5)Cumming School of Medicine- University of Calgary, Division of Gastroenterology & Hepatology- Department of Medicine, Calgary, Canada;(6)Landos Biopharma- Inc, Corporate Development, Blacksburg, United States;(7)Landos Biopharma- Inc, Medicine, Boston, United States;(8)IRCCS San Raffaele Scientific Institute- Vita-Salute San Raffaele University, Gastroenterology and Gastrointestinal Endoscopy Unit, Milan, Italy;
P1150: The sulfur microbial diet and prognosis of individuals with Inflammatory Bowel Disease in a prospective cohort studyECCO'24Year: 2024
Authors: Chen, J.(1,2)*;Dan, L.(2);Sun, Y.(3);Fu, T.(1);Wang, X.(1);
(1)The Third Xiangya Hospital- Central South University, Department of Gastroenterology, Changsha, China;(2)Zhejiang University, Center for Global Health, Hangzhou, China;(3)The Second Affiliated Hospital- Zhejiang University School of Medicine, Department of Gastroenterology, Hangzhou, China;
P1151: Incidence and risk factors of thromboembolic events in Pediatric-Onset Inflammatory Bowel Disease: a population-based studyECCO'24Year: 2024
Authors: Richard, N.(1)*;Leroyer, A.(2);Ley, D.(3);Dupont, C.(4);Bertrand, V.(5);Wils, P.(6);Gower-Rousseau, C.(7);Turck, D.(8);Guillon, N.(9);Sarter, H.(3);Savoye, G.(1);Fumery, M.(10);
(1)Univ Rouen Normandie- INSERM- ADEN UMR1073- “Nutrition- Inflammation and microbiota-gut-brain axis”- CHU Rouen, Department of Gastroenterology, F-76000 Rouen, France;(2)Regional House of Clinical Research- Lille University Hospital, Department of Public Health- Epidemiology- and Economic Health- EPIMAD Registry, Lille, France;(3)Univ. Lille- Inserm- CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France;(4)Caen University Hospital, Department of Pediatrics- Gastroenterology, Caen, France;(5)Le Havre Hospital, Department of Pediatrics, Le Havre, France;(6)Lille University Hospital, Department of Gastroenterology, F-59000 Lille, France;(7)Reims University Hospital, Research and Public Health Unit, Reims, France;(8)CHU Lille- Division of Gastroenterology- Hepatology- and Nutrition, Department of Pediatrics, F-59000 Lille, France;(9)Regional House of Clinical Research- Lille University Hospital, Department of Public Health- Epidemiology- and Economic Health- EPIMAD Registry, F-59000 Lille, France;(10)Amiens university Hospital, Department of Gastroenterology, Amiens, France;EPIMAD study group
P1153: Hospital surgical volumes and outcomes in ileocaecal resection for Crohn’s disease in Sweden 2000-2019: A national cohort studyECCO'24Year: 2024
Authors: Soop, M.(1)*;Zuk, D.(2);Bryder, M.(3);Myrelid, P.(4);Thorell, A.(2);Ludvigsson, J.F.(3);Olén, O.(3);Nordenvall, C.(1);
(1)Karolinska University Hospital, Department of IBD and Intestinal Failure Surgery, Stockholm, Sweden;(2)Ersta Hospital, Department of Surgery, Stockholm, Sweden;(3)Karolinska Institutet, Clinical Epidemiology Division- Department of Medicine, Stockholm, Sweden;(4)Linköping University Hospital, Department of Surgery, Linköping, Sweden;
P1154: Mediterranean dietary approaches to stop hypertension intervention for neurodegenerative delay (MIND) diet can reduce Inflammatory Bowel Disease risk: a prospective cohort studyECCO'24Year: 2024
Authors: Ye, S.(1);Sun, Y.(1,2);Chen, X.(1);Fu, T.(1);Ruan, X.(1);Dan, L.(3);Chen, J.(1,3)*;Du, Z.(4);,5;Wang, X.(1);
(1)The Third Xiangya Hospital- Central South University, Department of Gastroenterology, Changsha, China;(2)The Second Affiliated Hospital- Zhejiang University School of Medicine- Hangzhou- China, Department of Gastroenterology, Hangzhou, China;(3)Zhejiang University, Center for Global Health, Hangzhou, China;(4)Zhejiang Chinese Medical University, School of Basic Medical Sciences, Hangzhou, China;(5)Zhejiang Chinese Medical University, Key Laboratory of Blood-stasis-toxin Syndrome of Zhejiang Province, Hangzhou, China;
P1155: Impact of COVID19 pandemic and vaccination among IBD patients: a multinational cross sectional surveyECCO'24Year: 2024
Authors: Alavi NejadAss. Prof., P.(1)*;Mokhtare, M.(2);Farsi, F.(3);Arshadzadeh, M.(4);Shetty, S.(5);Eslami, O.(6);Arefi, M.(7);Emara, M.H.(8);Abdelsameea, E.(9);Rezaei, 1. .J.(10);Alavi, S.M.A.(10);Tran, Q.T.(11);Salma, R.(12);Parsi, A.(10);Ahmed, M.H.(13);Monged, A.(14);Quadri, A.(15);Jawad, A.(16);Rehman, A.U.(17);Lee, S.H.(18);Behl, N.S.(19);Ghoneem, E.(20);
(1)Ahvaz Jundishapur university of medical sciences, Alimentary Tract research Center- Ahvaz Imam Hospital, Copenhagen, Denmark;(2)Iran university of medical sciences, GI Department, Tehran, Iran- Islamic Republic Of;(3)Iran University of medical sciences, Minimally Invasive Surgery Research Center, Tehran, Iran- Islamic Republic Of;(4)Tehran University of medical Sciences, Faculty of medicine, Tehran, Iran- Islamic Republic Of;(5)Kasturba Medical College- Manipal University, Department of gastroenterology and hepatology, Kasturba, India;(6)Kerman University of Medical Sciences, Clinical research Development Unit- Afzalipour Hospital, Kerman, Iran- Islamic Republic Of;(7)Tehran University of Medical Sciences, Toxicology Center of Baharloo Hospital, Tehran, Iran- Islamic Republic Of;(8)Kaflelsheikh University, Faculity of Medicine- Department of Hepatology- Gastroenterology and Infectious diseases, Kafrelsheikh, Egypt;(9)Menoufia University, National Liver Institute, Menoufia, Egypt;(10)Ahvaz Jundishapur University of Medical sciences, Alimentary Tract research Center, Ahvaz, Iran- Islamic Republic Of;(11)Hue University, University of Medicine and pharmacy, Hue, Vietnam;(12)Zagazig University, Tropical Medicine Department, Kairo, Egypt;(13)Kafrelsheikh University, Gastroenterology and Infectious Diseases Department, Mansoura, Egypt;(14)Royal College of Surgeons of Ireland Hospitals, GI Department, Dublin, Ireland;(15)Dr VRK Woman’s Medical College, internal medicine hospital, Telangana, India;(16)Dr VRK womens Medical College, internal medicine department, Hyderabad, India;(17)Faisalabad Medical University, internal medicine department, Faisalabad, Pakistan;(18)Seoul National university Hospital, department of internal medicine and liver research institute, Seoul, Korea- Republic Of;(19)Fortis Hospitals, Institute of gastro and liver Sciences, Hyderabad, India;(20)Mansoura University, Gastroenterology and Hepatology Department, Mansoura, Egypt;
P1156: Characteristics and outcomes of over a million Inflammatory Bowel Disease patients in seven countries: a multinational cohort studyECCO'24Year: 2024
Authors: Weisshof, R.(1)*;Magen-Rimon, R.(2);Voss, E.(3);Swerdel, J.(3);Sheahan, A.(3);Hall , N.(3);Park, J.(4);Park , R.W.(5);Lee , K.J.(6);Sung , J.S.(6);Seo, S.I.(7);Lee , K.J.(8);Falconer , T.(4);Haas , L.(9);Nagy, P.(9);Bowring , M.(9);Cook, M.(9);Miller , S.(9);El-Hay , T.(10);Bivas-Benita , M.(10);Akiva , P.(10);Chowers, Y.(1);Yanover , C.(10);
(1)Rambam Health Care Campus, Department of Gastroenterology, Haifa, Israel;(2)Ruth Children@E@s Hospital of Haifa- Rambam Medical Center, Pediatric Gastroenterology & Nutrition institute, Haifa, Israel;(3)Janssen Pharmaceutical Research and Development, OHDSI Collaborators- Observational Health Data Sciences and Informatics, Titusville, United States;(4)Columbia University Irving Medical Center, Department of Biomedical Informatics, New York, United States;(5)Ajou University School of Medicine, Department of Biomedical Informatics, Suwon, Korea- Republic Of;(6)Ajou University School of Medicine, Department of Gastroenterology, Suwon, Korea- Republic Of;(7)Kangdong Sacred Heart Hospital, Department of Internal Medicine, Seoul, Korea- Republic Of;(8)Kangdong Sacred Heart Hospital, Department of Medical Informatics & Statistics, Seoul, Korea- Republic Of;(9)Johns Hopkins University School of Medicine, Division of Pediatric Gastroenterology- Hepatology and Nutrition- Department of Pediatrics, Baltimore, United States;(10)KI Research Institute, n/a, Kfar Malal, Israel;
P1157: Burden of herpes zoster in patients with inflammatory bowel disease treated with immunosuppressive agentsECCO'24Year: 2024
Authors: Chan, P.(1)*;Jorga, A.(2);Caldera, F.(3);Powell, N.(4);Yun, H.(5);
(1)GSK, Vaccines, Rockville- MD, United States;(2)GSK, Global Medical Affairs Shingrix, Rockville- MD, United States;(3)University of Wisconsin, Department of Medicine, Madison- WI, United States;(4)Imperial College London, Department of Metabolism- Digestion & Reproduction, London, United Kingdom;(5)GSK, Vaccines Epidemiology, Rockville- MD, United States;
P1158: Comparison of comorbidities, and lifestyle habits between IBD patients, IBD patients with suspected SpA, and controlsECCO'24Year: 2024
Authors: Karling, P.(1)*;Pettersson, N.(2);Forsblad-d´Elia, H.(3);
(1)Norrlands University Hospital NUS Umeå, Public Health and Clinical Medicine- Umeå University, Umeå, Sweden;(2)Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden;(3)Department of Rheumatology and Inflammatoin Research- University of Gothenburg, Region Sahlgrenska University Hospital- Department of Rheumatology, Gothenburg, Sweden;
P1159: Gene and environment interactions in inflammatory bowel disease: a systematic review of human epidemiologic studiesECCO'24Year: 2024
Authors: Bai, J.(1)*;Bouwknegt , D.(1);Weersma , R.(1);Dijkstra , G.(1);van der Sloot, K.(1);Festen , E.(1,2);
(1)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(2)University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands;
P115: Ustekinumab in DEVELOP: A safety analysis from an Inflammatory Bowel Disease multicenter, prospective, long-term registry of paediatric patientsECCO'24Year: 2024
Authors: Koletzko , S.(1);Veereman , G.(2);Hyams , J.(3);Dubinsky , M.(4);Godwin , B.(5);Busse , C.(6);Strauss , R.(7);Volger , S.(8);Wang , Y.(9);Griffiths , A.(10);Colletti , R.B.(11);Kugathasan , S.(12);Markowitz , J.(13);Winter , H.S.(14);Escher , J.(15);Baldassano , R.N.(16);Ruemmele , F.(17)*;Faubion , W.(18);Gold , B.(19);
(1)Ludwig Maximilians Universität München, Dr von Hauner Children@E@s Hospital, Munich, Germany;(2)Vrije Uniuversiteit Brussel, Universiteit Ziekenhuis, Brussels, Belgium;(3)Connecticut Children’s Medical Center, Gastroenterology, Hartford, United States;(4)Mount Sinai, Icahn School of Medicine, New York, United States;(5)Janssen Research & Development- LLC, Clinical Development Immunology, Spring House, United States;(6)Janssen Scientific Affairs- LLC, Medical Affairs, Horsham, United States;(7)Janssen Research & Development- LLC, Pediatric Development Program, Spring House, United States;(8)Janssen Research & Development- LLC, Pediatric Development Team, Spring House, United States;(9)Janssen Research & Development- LLC, Statistics and Decision Sciences, Spring House, United States;(10)University of Toronto, The Hospital for Sick Children, Toronto, Canada;(11)Emory University, Pediatrics, Burlington, United States;(12)Emory University, Children@E@s Healthcare of Atlanta Combined Center for Pediatric Inflammatory Bowel Disease, Atlanta, United States;(13)Cohen Children’s Medical Center of New York, Pediatric Gastroenterology, New York, United States;(14)Mass General Hospital for Children, Center for Pediatric Inflammatory Bowel Disease, Boston, United States;(15)Erasmus Mc-Sophia Children@E@s Hospital, Department of Pediatric Gastroenterology, Rotterdam, The Netherlands;(16)The Children@E@s Hospital of Philadelphia, Pediatric Inflammatory Bowel Disease, Philadelphia, United States;(17)Centre de référence maladies digestives rares MaRDI- Hôpital Universitaire Necker Enfants Malades, Service de Gastroentérologie et Nutrition pédiatrique, Paris, France;(18)Mayo Clinic, Children@E@s Center, Rochester, United States;(19)GI Care for Kids and Emory University Hospital, Pediatrics, Atlanta, United States;
P116: Risk of fractures in children and adults with inflammatory bowel disease: A report from the epi-IIRNECCO'24Year: 2024
Authors: Orlanski Meyer, E.(1)*;Buchuk, R.(1);Ben Tov, A.(2);Ledderman, N.(3);Loewenberg Weisband, Y.(4);Matz, E.(5);Dotan, I.(6);Turner, D.(1);Assa, A.(1);
(1)Shaare Zedek Medical Center, The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Jerusalem, Israel;(2)Macabbi Health Care Services, Macabbi Health Care Services, Tel Aviv, Israel;(3)Meuhed Health Services, Meuhedet, Tel Aviv, Israel;(4)Clalit Research Institute, Chief’s Office- Clalit Health Services, Tel Aviv, Israel;(5)Leumit Health Services, Leumit Health Services, Tel Aviv, Israel;(6)Division of Gastroenterology Rabin Medical Center- Petah Tikva- Israel, Sackler Faculty of Medicine- Tel Aviv University- Israel, Tel Aviv, Israel;
